Does this 8-K include any financial results or guidance for Astera Labs?

No. The filing covers only a board appointment, the related compensation, and an exhibit press release. It contains no financial results, revenue figures, or forward guidance.

Why did Astera Labs add a board member and expand the board to eight directors?

The filing does not state a specific reason. The press release describes Dr. Barratt's experience in scaling high-growth technology companies and his semiconductor and networking expertise, and says it will support the company's growth and AI connectivity strategy.

Is the compensation for Dr. Barratt material to investors?

The compensation is modest. It includes prorated retainers of $60,000 for Board service and $12,500 for Audit Committee service, plus a one-time RSU award valued at $330,000 that vests over three years. These amounts are unlikely to have a meaningful effect on the company's financial results.

Does Dr. Barratt's appointment change who oversees the company's audit?

Yes, in part. Dr. Barratt replaces Manuel Alba as a member of the Audit Committee, so his background in semiconductor and networking technology becomes part of audit oversight. The filing does not describe any change to the committee chair or other members.

When will Dr. Barratt next face stockholders?

He was designated a Class II director and plans to stand for election at the 2026 Annual Meeting of Stockholders.

ALAB 8-K: Leadership Changes

01—Abstract

Summary

Summary of the 8-K filed March 3, 2025. Cited figures are marked; the original filing is the authoritative source.

Astera Labs (ALAB) filed an 8-K on March 3, 2025 to disclose the appointment of Dr. Craig Barratt to its Board of Directors.

The Board expanded its size from seven to eight members and appointed Dr. Barratt effective March 2, 2025. The Board has determined he is independent under Nasdaq and SEC rules. He was designated a Class II director and intends to stand for election at the 2026 Annual Meeting of Stockholders.

He also replaces Manuel Alba on the Audit Committee. The filing is governance-focused and contains no financial results, guidance, or material operational updates. The appointment is a routine board refresh, and Dr. Barratt brings a long record in networking and semiconductor leadership, including his former roles as CEO of Barefoot Networks, President of Atheros, and SVP at Google, plus his current chair role at Intuitive Surgical.

For investors, the key governance points are the expanded board, the added audit committee expertise, and the standard compensation package. That package consists of a $60,000^a annual Board retainer, a $12,500 annual Audit Committee retainer (both prorated for 2025), and a one-time RSU award worth $330,000 vesting over three years. The disclosure has limited near-term financial impact.

The one-time RSU grant and retainers are modest relative to the company's scale, and the filing contains no related-party transactions or family relationships requiring disclosure. Investors should view this as a neutral governance event, with the main signal being the addition of a seasoned semiconductor and networking executive to oversight of a company focused on AI and cloud connectivity.

02—Key points

Key Highlights

Board expanded from seven to eight directors; Dr. Craig Barratt appointed effective March 2, 2025, and deemed independent under Nasdaq and SEC rules.
Dr. Barratt designated as a Class II director and expected to stand for election at the 2026 Annual Meeting of Stockholders.
He replaces Manuel Alba on the Audit Committee, adding semiconductor and networking expertise to audit oversight.
Compensation includes a $60,000 annual Board retainer and a $12,500 annual Audit Committee retainer, both prorated for 2025.
One-time RSU award with a fair market value of $330,000 under the 2024 Stock Option and Incentive Plan, vesting in equal annual installments over three years.
Dr. Barratt's background includes CEO of Barefoot Networks, President of Qualcomm Atheros, CEO of Atheros Communications, and SVP at Google, and he currently chairs Intuitive Surgical's board.
No related-party transactions under Item 404(a) and no family relationships with directors or executive officers; the filing contains no financial results or guidance.

03—Questions

Frequently Asked Questions

Does this 8-K include any financial results or guidance for Astera Labs?
No. The filing covers only a board appointment, the related compensation, and an exhibit press release. It contains no financial results, revenue figures, or forward guidance.
Why did Astera Labs add a board member and expand the board to eight directors?
The filing does not state a specific reason. The press release describes Dr. Barratt's experience in scaling high-growth technology companies and his semiconductor and networking expertise, and says it will support the company's growth and AI connectivity strategy.
Is the compensation for Dr. Barratt material to investors?
The compensation is modest. It includes prorated retainers of $60,000 for Board service and $12,500 for Audit Committee service, plus a one-time RSU award valued at $330,000 that vests over three years. These amounts are unlikely to have a meaningful effect on the company's financial results.
Does Dr. Barratt's appointment change who oversees the company's audit?
Yes, in part. Dr. Barratt replaces Manuel Alba as a member of the Audit Committee, so his background in semiconductor and networking technology becomes part of audit oversight. The filing does not describe any change to the committee chair or other members.
When will Dr. Barratt next face stockholders?
He was designated a Class II director and plans to stand for election at the 2026 Annual Meeting of Stockholders.

04—Continue

← View all 8-K filings